Compare PRPL & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | ZTEK |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | Canada |
| Employees | N/A | 18 |
| Industry | Home Furnishings | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 68.8M |
| IPO Year | 2015 | 2022 |
| Metric | PRPL | ZTEK |
|---|---|---|
| Price | $0.70 | $0.63 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 212.8K | 134.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.22 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $487,877,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.69 | N/A |
| P/E Ratio | $1.60 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.54 |
| 52 Week High | $1.26 | $1.84 |
| Indicator | PRPL | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 42.44 |
| Support Level | $0.65 | $0.55 |
| Resistance Level | $0.74 | $0.75 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 80.04 | 53.92 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.